Skyhawk news

Browse:

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

May 12, 2020
Skyhawk Therapeutics boosts Merck collab pact with added targets, upfront and biobucks
Read
2 min read
May 12, 2020
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Skyhawk will deploy its SkySTAR™ platform to develop drug candidates directed to multiple new targets for autoimmune and metabolic diseases
Read
2 min read
May 12, 2020
Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
Read
2 min read
April 6, 2020
The 20 under 40 : Inside the next generation of biopharma leaders
Read
5 min read
February 24, 2020
Experienced Business Leader in Biopharmaceutical Industry Joins as Chief Operating Officer at Skyhawk Therapeutics
Dr. Terrance Connolly brings over 20 years of biotech operations and business development experience to his role as Chief Operating Officer Skyhawk Therapeutics
Read
2 min read